pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,150 catalysts · 4,876 phase readout · 2,346 8k filing · 286 earnings · 274 pdufa · 129 phase 2 completion · 61 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 16 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: recall×type: pdufa×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,346
  • earnings286
  • pdufa274
  • phase 2 completion129
  • phase 1 completion61
phase 1 initiation
32
  • phase 1 2 completion28
  • phase 0 trial completion22
  • phase 2 initiation16
  • therapy area
    • Infectious Disease1

    Date TBD

    50
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05945550: Comparison of Complication Rates Between Initial and Re-operative Anterior Lumbar Interbody Fusion Surgery: Is There a Difference?

    Sponsor: Methodist Health System. Phase: . Conditions: Lumbar Spondylolisthesis, Lumbar Spine Degeneration

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05816174: Longitudinal Study of Chronic Postsurgical Pain in Children and Adolescents

    Sponsor: Helen Koechlin. Phase: . Conditions: Chronic Post Operative Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05540574: Trial of Zolpidem for Sleep in Children With Autism

    Sponsor: Stanford University. Phase: PHASE2. Conditions: Autism, Autism Spectrum Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05671874: Feasibility of a Digital Goals-of-Care Decision Aid for Clinicians and Families of Patients With SABI

    Sponsor: University of Massachusetts, Worcester. Phase: NA. Conditions: Hemorrhagic Stroke, Intracerebral, Acute Ischemic Stroke, Traumatic Brain Injury

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02905318: Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer

    Sponsor: Canadian Cancer Trials Group. Phase: PHASE2. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07477990: Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device in Adult Patients With Moderate to Severe Generalized Anxiety Disorder

    Sponsor: Psicofarma, S.A. De C.V.. Phase: PHASE3. Conditions: General Anxiety Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07547397: COMPARISON OF CLASSICAL AND SYRINGE-FREE TECHNIQUES IN ULTRASOUND-GUIDED CENTRAL JUGULAR VENOUS CATHETERIZATION

    Sponsor: ALİEMAN. Phase: NA. Conditions: Central Venous Catheters/Standards, Ultrasonography/Methods, Ultrasonography/Standards

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07464197: Effectiveness of Dental Bleaching Using Different Designs of 3D-Printed and Conventional Customized Nightguards

    Sponsor: Universitat Internacional de Catalunya. Phase: NA. Conditions: Tooth Discoloration, Tooth Staining

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07341997: Environmental Factors Associated With Peripheral Neuropathies in French Guiana

    Sponsor: Admin CIC. Phase: NA. Conditions: Peripheral Neuropathies, Environmental Risk Factor, Lead Neuropathy, Mercury Neuropathy, Bita

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07188610: PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma

    Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.. Phase: PHASE2. Conditions: CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT04132310: Mother Infant Nutrition Study

    Sponsor: University of Texas at Austin. Phase: . Conditions: Pregnancy Related, Infant Development

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07619560: Developing Precision Microbiota-Based Cocktail Modification Therapy to Delay the Progression of Parkinson's Disease (PD) - Use Preclinical Human Trials to Confirm the Impact of the Optimal "Probiotic Y7, Tryptophan and Branched-chain Amino Acid" Cocktail Formula on Early Stage PD Patients

    Sponsor: Taipei Medical University. Phase: NA. Conditions: Parkinson Disease (PD), Gut Microbiota, Probiotic

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07626320: Effectiveness of a Sound Bowl Meditation on Caregiver Stress and Anxiety

    Sponsor: Ohio State University. Phase: NA. Conditions: Stress, Anxiety

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06369220: A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections

    Sponsor: Hoffmann-La Roche. Phase: NA. Conditions: Chlamydia Trachomatis Infection, Neisseria Gonorrhoeae Infection, Mycoplasma Genitalium Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07661524: Passive Versus Active Music Therapy Parkinson's Disease

    Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Parkinson Disease (PD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06795282: Post Operative Sensitivity of MTA Obturation

    Sponsor: TC Erciyes University. Phase: . Conditions: Dental Pulp Disease, Endodontically Treated Teeth, Endodontic Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07621224: Multimorbidity and Polypharmacy in People With HIV vs. the General Population in the Basque Country

    Sponsor: Biogipuzkoa Health Research Institute. Phase: . Conditions: HIV (Human Immunodeficiency Virus)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04091724: Perioperative EEG-Monitoring and Emergence Delirium in Children

    Sponsor: Huazhong University of Science and Technology. Phase: . Conditions: Delirium

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06140823: Prospective Validation of Liver Cancer Risk Computation (LIRIC) Models

    Sponsor: Beth Israel Deaconess Medical Center. Phase: . Conditions: Predictive Cancer Model

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07327359: A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia

    Sponsor: Olix Pharmaceuticals, Inc.. Phase: PHASE1. Conditions: Androgenetic Alopecia (AGA)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07658859: Emotional Freedom Techniques in Nursing Students With Primary Dysmenorrhea

    Sponsor: Ataturk University. Phase: NA. Conditions: PRIMARY DYSMENORRHEA

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07298980: ExBRAC- Expressive Writing in Breast Cancer

    Sponsor: Region Skane. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05557162: Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Cardiac Amyloidosis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03808662: Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: TNBC - Triple-Negative Breast Cancer, Triple Negative Breast Cancer, NSCLC, NSCLC Stage IV, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, NSCLC Stage IV Without EGFR/ALK Mutation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04001946: Clinical Trial of Gastrostomy Button Securement Device

    Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Gastrostomy Complications

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07518446: Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)

    Sponsor: Amager Hospital. Phase: NA. Conditions: Atrial Fibrillation (AF), Heart Failure, Asthma (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD), Diabetes, Cancer, Psychiatric Patients, Serious Medical Illness

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07519746: Satisfaction and Quality of Life Among Prosthetic Users in Gaza Governorate ,

    Sponsor: Yeditepe University. Phase: . Conditions: Amputation, Prosthesis User, Satisfaction, Quality of Lifte

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07696988: PNS to Improve Vascular Function and Limb Health in Veterans

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Lower Limb Amputees, Diabetes

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07639827: A Study of a Mental Fitness Intervention for Anesthesiology Resident Wellbeing and Self-Compassion

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Wellness, Self Compassion, Burnout, Anxiety, Depression

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03475186: Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

    Sponsor: Wake Forest University Health Sciences. Phase: PHASE2. Conditions: Glioblastoma, Radiotherapy; Complications, Cognitive Decline, Chemoradiation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06842186: A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity

    Sponsor: Wave Life Sciences USA, Inc.. Phase: PHASE1. Conditions: Overweight and Obesity

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05401786: Anti-PD-1 Re-challenge After Immune Priming by Ipilimumab and Immune Boosting by Radiotherapy in Advanced NSCLC

    Sponsor: The Netherlands Cancer Institute. Phase: PHASE2. Conditions: Carcinoma, Non-Small-Cell Lung

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04610086: Shared Decision Making and Satisfaction With the Diagnostic-therapeutic Process in the Shared Decision Making and Satisfaction With Colorectal Cancer Screening. The CyDESA Study

    Sponsor: Corporacion Parc Tauli. Phase: . Conditions: Colorectal Cancer, Satisfaction, Patient

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06181370: Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF

    Sponsor: Agomab Spain S.L.. Phase: PHASE1. Conditions: IPF

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07280273: Effectiveness of Pain Science Education in Patients With Fibromyalgia Syndrome Living in Rural Areas.

    Sponsor: María Catalina Osuna Pérez. Phase: NA. Conditions: Fibromyalgia Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07284069: Senicapoc and Perampanel for Newly Diagnosed Glioblastoma

    Sponsor: Aarhus University Hospital. Phase: EARLY_PHASE1. Conditions: Glioblastoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04864054: GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

    Sponsor: Eureka Therapeutics Inc.. Phase: PHASE1. Conditions: Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Neoplasm, Metastatic Liver Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07369635: A Phase III Clinical Trial Evaluating the Efficacy and Safety of TriThien Duoc Capsules in Grade II Internal Haemorrhoids Patients With Bleeding Compared to Diosmin.

    Sponsor: Hanoi Medical University. Phase: PHASE3. Conditions: Grade II Internal Hemorrhoids With Bleeding

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06719635: Management Modalities of Chronic Pelvic Pain

    Sponsor: Zagazig University. Phase: NA. Conditions: Pain, Chronic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04829617: Promoting Well-being and Health in Heart Failure

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Heart Failure, Heart Failure NYHA Class I, Heart Failure NYHA Class II, Heart Failure NYHA Class III

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06626789: Brain Signal Training to Enhance Affect Down-regulation

    Sponsor: Central Institute of Mental Health, Mannheim. Phase: PHASE1. Conditions: Borderline Personality Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07480668: Aromatherapy for Mental Health Promotion in IVF Patients

    Sponsor: Federal University of Minas Gerais. Phase: NA. Conditions: Anxiety, Stress, Depression Disorder, Quality of Life, Aromatherapy, IVF, Complementary Therapies, Spirituality, Infertility

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04341350: Comparison of an Inhaled Sedation Strategy to an Intravenous Sedation Strategy in Intensive Care Unit Patients Treated With Invasive Mechanical Ventilation

    Sponsor: University Hospital, Brest. Phase: PHASE3. Conditions: Prevention of Delirium

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT04661891: Real-time Neuromuscular Control of Exoskeletons

    Sponsor: Shirley Ryan AbilityLab. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02263274: Direct Cortical Measurement of the Intensity and Pattern of Current Flow Produced by TDCS

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Epilepsy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07640620: Relationship Between Central Sensitization and Clinical Features in Plantar Fasciitis

    Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey. Phase: . Conditions: Plantar Fasciitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07287124: A Pivotal Study to Evaluate the Clinical Benefit, Performance and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults

    Sponsor: Cochlear. Phase: NA. Conditions: Hearing Loss, Bilateral Sensorineural

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07676682: INVESTIGATİON OF THE EFFECT OF PASSIVE UTERINE STRAIGHTENING WITH A FULL BLADDER IN COMBINATION WITH TRANSABDOMINAL ULTRASONOGRAPHY ON PREGNANCY RATES IN INTRAUTERINE INSEMINATION: A PROSPECTIVE COHORT STUDY

    Sponsor: Firat University. Phase: . Conditions: Passive Uterine Straightening

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07377682: Real-world Clinical Response to Trazodone in Italy, Poland, and Romania

    Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A. Phase: . Conditions: Depression - Major Depressive Disorder, Cognition Disorders in Old Age

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03670524: Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project

    Sponsor: University of Louisville. Phase: NA. Conditions: Cardiovascular Diseases, Metabolic Health

    full page →ctgov ↗
    ← prev
    page 87 of 103
    next →